Core Viewpoint - Septerna, Inc. is participating in the 8th Annual Evercore Healthcare Conference, highlighting its focus on G protein-coupled receptor (GPCR) drug discovery and its innovative approach in the biotechnology sector [1]. Company Overview - Septerna, Inc. is a clinical-stage biotechnology company specializing in GPCR drug discovery, aiming to address significant unmet medical needs through its proprietary Native Complex Platform™ [3]. - The company has developed a diverse pipeline of novel oral small molecule drug candidates targeting various therapeutic areas, including endocrinology, immunology, inflammation, and metabolic diseases [3]. Event Participation - Management will engage in a fireside chat at the conference on December 2, 2025, at 10:25 a.m. ET, indicating the company's commitment to investor relations and transparency [1]. - A live webcast of the presentation will be available on the company's website, ensuring accessibility for investors and stakeholders [2].
Septerna to Participate in 8th Annual Evercore Healthcare Conference